Search Results 721-730 of 16658 for pharmacogenetics
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
ROCHESTER, Minn. — At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart ...
The ultimate goal of this biorepository will be to provide the resource to initiate an exploration of ctDNA as a potential liquid biopsy for GI and Thoracic ...
Mayo Clinic's Epigenetic Etiology of Human Disease Lab, led by Keith D. Robertson, Ph.D., studies DNA methylation and hydroxymethylation in health and ...
The collected tissue specimens will be used to develop preclinical models; i.e., cell lines, patient derived micro-cancer models as well as patient-derived ...
About this study. The purpose of this study is to assess the decision-making process in women who have Von Willebrand disease, regarding their attitudes and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The study details whole-genome genotype and gene expression patterns on 2,655 individuals, including people with dementia and those without it. The data ...
The purpose of this study is to create a patient-centered research partnership with a stakeholder advisory group (SAB) to adapt the Duke Transgender and Gender ...
PHOENIX — Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.